News About: Pharm. Industry
Biotoxtech, “Rumor about purchasing Celltrion’s stocks is groundless information”
Regarding the Korea Exchange’s request for an inquiry notice on the 17th, Biotoxtech announced on the 18th “We have no important information to particularly notice for the recent significant change in the market condi...
CJ HealthCare’s ‘Anfrade’ exceeds KRW 20 billon prescriptions in market of its substance
The ‘Anfrade’ series, a CJ HealthCare’s line of chronic peripheral artery disease therapies, first passed KRW 20 billion sales in the market of the same substance.
CJ HealthCare announced on the 18th that its Anfrade...
30 pharmas including Hanmi Pharm challenge the ‘diabetic neuropathy therapy market’
Since ‘Dexid(generic name: R-thioctic acid tromethamine),’ a diabetic neuropathy therapy, was expired for the PMS(Post-Marketing Surveillance), 30 pharmaceutical companies including Hanmi Pharm and Chong Kun Dang are ...
Ilyang Pharm’s ‘Prion Treatment Development’ selection as study supported by MOHW
The Ilyang Pharm’s(CEO Dong-Yeon Kim) development of prion treatment has recently been selected as the ‘Development of Technology to Overcome Diseases Transmitted Cross-species to Humans’ by the Ministry of Health and...
Daewoong Pharmaceutical’s Ursa challenges U.S. market with new look
‘Ursa’ will have a new look in 58 years of its launch. Daewoong Pharmaceutical is currently taking a new direction to renew the product which has grown 20% up in sales for the past 3 years.
With the uptrend, it is al...
Siemens Healthineers, “We’ll file a suit because the FTC’s decision infringed intellectual properties.”
Siemens Healthineers Korea(CEO/President Myung-Gyun Lee) announced that not only was the result of discussion the Fair Trade Commission(FTC) announced about the Siemens’ misuse of superiority in market on the 17th not...
Yuhan Corporation Jung-Hee Lee internally nominated as next Chair
Yuhan Corporation CEO Jung-Hee Lee was nominated as the next Chair of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association(KPBMA). Ever since Chair Heng-Myung Lee refused to continue the position with a w...
GC Pharma getting closer to world’s first commercialized recombinant protein for hepatitis B
GC Pharma(CEO Eun-Cheol Huh), formally known as Green Cross, announced on the 18th that the Phase II/III clinical trial plan for ‘GC1102(Hepabig-gene),’ a recombinant immunoglobulin for the treatment of hepatitis B, h...
Medtronic appoints President Hee-Yeol Lee as Asia-Pacific Head
Medtronic appointed President Hee-Yeol Lee(English name: Chris Lee) as Asia-Pacific Business Head.
In Singapore where its Asia-Pacific headquarters are located, President Hee-Yeol Lee will generally manage the busine...
Huons targets global eye drop market with extensive enlargement of manufacturing facilities
A subsidiary of Huons Global, Huons(CEO Gi-Ahn Um) will extensively enlarge manufacturing lines at its factory in Jecheon, Chungbuk to target the global eye drop market.
According to Huons, the company has decided to...
